July 16, 2025 Characterizing Tau Accumulation and Amyloid-tau Interactions in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial and Their Implications for Advancing Drug Development
July 16, 2025 Impact of non-linear SUVR transformations on the statistical power of tau-PET longitudinal studies
June 26, 2025 The Critical Path Institute Podcast: Connecting the Dots with DCC This newest Critical Path Institute® (C-Path) podcast episode provides an in-depth exploration of one of C-Path's core teams...
June 17, 2025 Honoring Progress and Hope Amidst Alzheimer’s and Brain Awareness Month Each June, we come together to recognize Alzheimer’s and Brain Awareness Month—a time to raise visibility for the 55 million..
April 25, 2025 Developing digital health technologies for frontotemporal degeneration Frontotemporal degeneration (FTD) is a rare neurodegenerative disease in which patients can present with cognitive, behavioral...
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer dis
January 31, 2017 Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients
